Personal information

No personal information available

Activities

Employment (1)

The Hospital for Sick Children: Toronto, ON, CA

2021-07-01 to 2023-06-30 | Fellow (Pediatric Oncology )
Employment
Source: Self-asserted source
Gabriel Revon-Rivière

Works (10)

Impact of the COVID‐19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE

Pediatric Blood & Cancer
2025-01 | Journal article
Contributors: Gemma Bryan; Louise Guolla; Gabriela Inés Villanueva; Sarah Cohen‐Gogo; Alejandra Casanovas; Rina Medina; Gabriel Revon‐Riviere; Hallie Coltin; Lisa S. Kahalley; Janice S. Withycombe et al.
Source: check_circle
Crossref

Upfront immunotherapy for synchronous high‐grade glioma and B‐lymphoma in a pediatric patient with CMMRD syndrome

Pediatric Blood & Cancer
2025-01 | Journal article
Contributors: Thérèse De Vanssay; Nour El Riachy; Caroline Donze; Romain Appay; Didier Scavarda; Benoit Testud; Nicolas Andre; Gabriel Revon‐Rivière
Source: check_circle
Crossref

Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer

Pediatric Blood & Cancer
2024-11 | Journal article
Contributors: Gabriel Revon‐Riviere; Denise Connolly; Sarah Cohen‐Gogo
Source: check_circle
Crossref

Upfront immunotherapy for synchronous high-grade glioma and B-lymphoma in a pediatric patient with CMMRD syndrome.

2024-09-01 | Preprint
Contributors: Vanssay T; El Riachy N; Caroline DONZE; Romain Appay; Didier Scavarda; Testud B; Nicolas André; Gabriel Revon-Riviere
Source: check_circle
Crossref

Personalised treatment plan for children and adolescents with advanced haematological malignancies: a response to paediatric relapsed acute leukaemia: curative intent chemotherapy improves quality of life

BMJ Supportive & Palliative Care
2024-05 | Journal article
Contributors: Gabriel Revon-Rivière; Arthur Sterin; Paul Saultier
Source: check_circle
Crossref

Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada

Cancer Medicine
2024-02 | Journal article
Contributors: Sandra Judd; Gabriel Revon‐Riviere; Stephanie A. Grover; Rebecca J. Deyell; Magimairajan Issai Vanan; Victor A. Lewis; Lucie Pecheux; Alexandra P. Zorzi; Catherine Goudie; Raoul Santiago et al.
Source: check_circle
Crossref

Ensuring access to innovative therapies for children, adolescents, and young adults across Canada: The single patient study experience

Paediatrics & Child Health
2023-10-25 | Journal article
Contributors: Gabriel Revon-Riviere; Leah C Young; Elizabeth A Stephenson; Kathy Brodeur-Robb; Sarah Cohen-Gogo; Rebecca Deyell; Thierry Lacaze-Masmonteil; Antonia Palmer; Rulan S Parekh; James A Whitlock et al.
Source: check_circle
Crossref

Blood-Derived Liquid Biopsies Using Foundation One® Liquid CDx for Children and Adolescents with High-Risk Malignancies: A Monocentric Experience

Cancers
2022-06-02 | Journal article
Contributors: Fanny Cahn; Gabriel Revon-Riviere; Victoria Min; Angélique Rome; Pauline Filaine; Annick Pelletier; Sylvie Abed; Jean-Claude Gentet; Arnauld Verschuur; Nicolas André
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience

European Journal of Cancer
2021-09 | Journal article
Contributors: Gabriel Revon-Riviere; Laetitia Ninove; Victoria Min; Angélique Rome; Carole Coze; Arnauld Verschuur; Xavier de Lamballerie; Nicolas André
Source: check_circle
Crossref

First step toward high‐intensity end‐of‐life care definition in pediatric oncology: Response to bereaved parents' views on end‐of‐life care for children with cancer: Quality marker implications

Cancer
2021-01-15 | Journal article
Contributors: Gabriel Revon‐Rivière; Sarah Szepetowski; Paul Saultier; Nicolas André
Source: check_circle
Crossref

Peer review (3 reviews for 2 publications/grants)

Review activity for BMJ supportive & palliative care. (1)
Review activity for EJC paediatric oncology. (2)